427
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Pathogenic mechanisms contributing to thrombocytopenia in patients with systemic lupus erythematosus

, , , , , , , , , , , , & ORCID Icon show all
Pages 743-754 | Received 27 Aug 2020, Accepted 20 Sep 2021, Published online: 21 Nov 2021

References

  • Fayyaz A, Igoe A, Kurien BT, Danda D, James JA, Stafford HA, Scofield RH. Haematological manifestations of lupus. Lupus Sci Med 2015;2(1):e000078. 10.1136/lupus.2014-000078
  • Galil SMA, Edrees AM, Ajeeb AK, Aldoobi GS, El-Boshy M, Hussain W. Prognostic significance of platelet count in SLE patients. Platelets 2017;28(2):203–207. 10.1080/09537104.2016.1214253
  • Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis. Platelets 2010;21(5):380–385. 10.3109/09537101003735564
  • McKenzie SE, Taylor SM, Malladi P, Yuhan H, Cassel DL, Chien P, Schwartz E, Schreiber AD, Surrey S, Reilly MP. The role of the human Fc Receptor FcγRIIA in the immune clearance of platelets: a transgenic mouse model. J Immunol 1999;162:4311–4318. PMID: 10201963.
  • McMillan R, Longmire RL, Tavassoli M, Armstrong LCS, Yelenosky R. In vitro platelet phagocytosis by splenic leukocytes in idiopathic thrombocytopenic purpura. N Engl J Med 1974;290(5):249–251. 10.1056/NEJM197401312900505
  • Catani L, Fagiolia ME, Tazzarib PL, Ricci F, Curti A, Rovito M, Preda P, Chirumbolo G, Amabile M, Lemoli RM, et al. Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes. Exp Hematol 2006;34(7):879–887. 10.1016/j.exphem.2006.03.009
  • Winkler J, Kroiss S, Rand ML, Azzouzi I, Bang KWA, Speer O, Schmugge M. Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin. Br J Haematol 2012;156(4):508–515. 10.1111/j.1365-2141.2011.08973.x
  • Goette NP, Glembotsky AC, Lev PR, Grodzielski M, Contrufo G, Pierdominici MS, Espasandin YR, Riveros D, García AJ, Molinas FC, et al. Platelet apoptosis in adult immune thrombocytopenia: insights into the mechanism of damage triggered by auto-antibodies. PLoS One 2016;11(8):e0160563. 10.1371/journal.pone.0160563.
  • Deng G, Yu S, Li Q, He Y, Liang W, Yu L, Xu D, Sun T, Zhang R, Li Q. Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia. Hematology 2017;22(3):155–161. 10.1080/10245332.2016.1237004
  • Deppermann C, Kratofil RM, Peiseler M, David BA, Zindel J, Vargas F, Silva Castanheira E, Van Der Wal F, Carestia A, Jenne CN, et al. Macrophage galactose lectin is critical for Kupffer cells to clear aged platelets. J Exp Med 2020;217(4):e20190723. 10.1084/jem.20190723
  • Li J, Van Der Wal DE, Zhu G, Xu M, Yougbare I, Ma L, Vadasz B, Carrim N, Grozovsky R, Ruan M, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Comm 2015;6(1):7737. 10.1038/ncomms8737.
  • Qiu J, Liu X, Li X, Zhang X, Han P, Zhou H, Shao L, Hou Y, Min Y, Kong Z, et al. CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia. Sci Rep 2016;6(1):27445. 10.1038/srep27445
  • Guo T, Wang X, Qu Y, Yin Y, Jing T, Zhang Q. Megakaryopoiesis and platelet production: insight into hematopoietic stem cell proliferation and differentiation. Stem Cell Investig 2015;2:3. 10.3978/j.issn.2306-9759.2015.02.01
  • McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 2004;103(4):1364–1369. 10.1182/blood-2003-08-2672
  • Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, Nugent DJ. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 2003;102(3):887–895. 10.1182/blood-2002-05-1475
  • Lev PR, Grodzielski M, Goette NP, Glembotsky AC, Espasandin YR, Pierdominici MS, Contrufo G, Montero VS, Ferrari L, Molinas FC, et al. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count. Br J Haematol 2014;165(6):854–864. 10.1111/bjh.12832.
  • Grodzielski M, Goette NP, Glembotsky AC, Baroni Pietto MC, Méndez-Huergo SP, Pierdominici MS, Montero VS, Rabinovich GA, Molinas FC, Heller PG, et al. Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia. Sci Rep 2019;9(1):2208. 10.1038/s41598-018-38086-1.
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725. 10.1002/art.1780400928
  • Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677–2686. 10.1002/art.34473
  • Glembotsky AC, Bluteau D, Espasandin YR, Goette NP, Marta RF, Marin Oyarzun CP, Korin L, Lev PR, Laguens RP, Molinas FC, et al. Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets. J Thromb Haemostasis 2014;12:761–772. 10.1111/jth.12550.
  • Balduini A, Pallotta I, Malara A, Lova P, Pecci A, Viarengo G, Balduini CL, Torti M. Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. J Thromb Haemost 2008;6(11):1900–1907. 10.1111/j.1538-7836.2008.03132.x
  • Lood C. Tyde ́NH, Gullstrand B, Sturfelt G, Jonsen A, Truedsson J, Bengtsson AA. Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in Systemic Lupus Erythematosus. PLoS ONE 2014;9:e99386. 10.1371/journal.pone.0099386
  • Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus? Semin Arthritis Rheum 2019;48(6):1035–1040. 10.1016/j.semarthrit.2018.10.013
  • Nagahama M, Nomura S, Ozaki S, Yoshimura C, Kagawa H, Fukuhara S. Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity 2001;33:85–94. 10.3109/08916930108995993
  • Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet–leukocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001;115:451–459. 10.1046/j.1365-2141.2001.03101.x
  • Nhek S, Clancy R, Lee KA, Allen NM, Barrett TJ, Marcantoni E, Nwaukoni J, Rasmussen S, Rubin M, Newman JD, et al. Activated platelets induce endothelial cell activation via an Interleukin-1β pathway in Systemic Lupus Erythematosus. Arterioscler Thromb Vasc Biol 2017;37(4):707–716. 10.1161/ATVBAHA.116.308126
  • Cloutier N, Allaeys I, Marcoux G, Machlus KR, Mailhot B, Zufferey A, Levesque T, Becker Y, Tessandier N, Melki I, et al. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration. Proc Nat Acad Sci 2018;115(7):E1550–E1559. 10.1073/pnas.1720553115.
  • Grozovsky R, Begonja AJ, Liu K, Visner G, Hartwig JH, Falet H, Hoffmeister KM. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med 2015;21(1):47–54. 10.1038/nm.3770
  • Pujol M, Ribera A, Vilardell M, Ordi J, Feliu E. High prevalence of platelet autoantibodies in patients with systemic lupus erythematosus. Br J Haematol 1995;89(1):137–141. 10.1111/j.1365-2141.1995.tb08919.x
  • Duffau P, Seneschal J, Nicco C, Richez C, Lazaro E, Douchet I, Bordes C, Viallard JF, Goulvestre C, Pellegrin JL, et al. Platelet CD154 potentiates Interferon-a secretion by plasmacytoid dendritic cells in Systemic Lupus Erythematosus. Sci Transl Med 2010;2:47ra63. 10.1126/scitranslmed.3001001.
  • Shah D, Sah S, Wanchu A, Wu MX, Bhatnagar A. Altered redox state and apoptosis in the pathogenesis of systemic lupus erythematosus. Immunobiology 2013;218(4):620–627. 10.1016/j.imbio.2012.07.030
  • Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:201–211. 10.1002/art.20745
  • Lu C, Nossent J. Thrombopoietin levels in systemic lupus erythematosus are linked to inflammatory cytokines, but unrelated to thrombocytopenia or thrombosis. Lupus 2015;24(1):18–24. 10.1177/0961203314547796
  • Chun HY, Chung JW, Kim HA, Yun JM, Jeon JY, Ye YM, Kim SH, Park HS, Suh CH, Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 2007;27:461–466. 10.1007/s10875-007-9104-0
  • Horii Y, Iwano M, Hirata E, Shiiki M, Fujii Y, Dohi K, Ishikawa H. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int Suppl 1993;39:S71–5. PMID: 8468929.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.